
Mounjaro Injection 5mg
$49 - $290
Mounjaro Injection 5mg is a prescription medicine containing tirzepatide, designed to help manage type 2 diabetes in adults. Administered once weekly under the skin, it improves blood sugar control by targeting two key hormone pathways (GIP and GLP-1).
- Product id
- Delivery
- USA, UK, Europe, Australia, South Africa and other
PACK SIZE | PRICE | QTY | ADD TO CART | |
---|---|---|---|---|
1 Vial | ($49/Vial) |
|||
3 Vial | ($48.33/Vial) |
|||
6 Vial | ($48.33/Vial) |
|||
Mounjaro Injection 5mg is a groundbreaking prescription medication designed to improve blood sugar control in adults with type 2 diabetes mellitus. Containing Tirzepatide (5 mg per 0.5 mL), this once-weekly subcutaneous injection is the first dual GIP and GLP-1 receptor agonist, offering a unique approach to glycemic management. Manufactured by Eli Lilly and Company, a trusted leader in diabetes care, Mounjaro 5 mg is used alongside diet and exercise to help lower blood glucose levels and support weight loss, making it a versatile option for those seeking better metabolic health. It’s not intended for type 1 diabetes or children under 18.
Key Features
- Active Ingredient: Tirzepatide (5 mg), a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
- Purpose: Enhances glycemic control in adults with type 2 diabetes and promotes weight loss as a secondary benefit when paired with lifestyle changes.
- Packaging: Supplied as a single-dose, prefilled injection pen delivering 0.5 mL, available in packs of 4 pens (one month’s supply).
- Quality Assurance: Manufactured under stringent Good Manufacturing Practices (GMP) by Eli Lilly, ensuring safety, potency, and reliability.
Benefits
- Dual-Action Power: Activates GIP and GLP-1 receptors to boost insulin release, reduce liver glucose production, and slow digestion, delivering superior blood sugar control.
- Weight Loss Support: Clinical trials show significant weight reduction (up to 22.5% of body weight at higher doses over 72 weeks), aiding overall health improvement.
- Once-Weekly Dosing: Simplifies treatment with a single, easy-to-use injection, enhancing adherence and convenience.
- Flexible Administration: Can be taken with or without food, at any time of day, fitting seamlessly into your routine.
How It Works
Mounjaro’s Tirzepatide mimics and enhances the effects of GIP and GLP-1, two incretin hormones. It stimulates insulin secretion when blood sugar rises, suppresses glucagon to limit glucose release from the liver, and slows gastric emptying to curb appetite and stabilize post-meal glucose spikes. This dual mechanism not only lowers HbA1c but also supports weight loss by reducing hunger and increasing satiety, making it a standout in type 2 diabetes management.
Dosage and Administration
- Recommended Dose: One 5 mg injection weekly, administered subcutaneously in the abdomen, thigh, or upper arm. Typically follows a 4-week initiation with 2.5 mg, with potential increases (up to 15 mg max) every 4 weeks if needed, per doctor’s guidance.
- Instructions: Use the prefilled pen as shown by your healthcare provider rotate injection sites weekly. If missed, take within 4 days; otherwise, skip and resume the regular schedule.
- Note: Do not mix with insulin in the same syringe, though both can be injected in the same body area (not adjacent). Consult your doctor for personalized dosing.
Safety Information
- Side Effects: Common effects include nausea, diarrhea, vomiting, constipation, and injection site reactions usually mild and decreasing over time. Serious risks (rare) include pancreatitis (severe abdominal pain), thyroid tumors (neck swelling), or allergic reactions seek immediate help if these occur.
- Precautions: Contraindicated in patients with a personal/family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Not for use in pancreatitis history without caution. May increase hypoglycemia risk with insulin/sulfonylureas monitor closely. Avoid in pregnancy/breastfeeding unless advised.
- Storage: Refrigerate at 36°F-46°F (2°C-8°C) in its original carton do not freeze. Can be kept at room temperature (up to 86°F/30°C) for 21 days if needed.
Why Choose Mounjaro 5 mg Injection?
Mounjaro 5 mg Injection redefines type 2 diabetes care with its innovative dual-action formula, offering robust glucose control and meaningful weight loss in one sleek pen. Backed by Eli Lilly’s expertise, it’s a premium yet practical choice for adults aiming to manage their condition and enhance their well-being. Simple, effective, and clinically proven it’s your partner in a healthier tomorrow.
Active Ingredient | Tirzepatide (5mg) |
---|---|
Manufacturer | Eli Lilly and Company India Pvt Ltd |
Delivery Time | 7 To 14 Days |
SKU: |
What is Mounjaro 5mg used for?
Mounjaro 5mg (tirzepatide) is used to improve blood sugar control in adults with type 2 diabetes. It may also aid in weight management when combined with a healthy diet and exercise.
How is Mounjaro 5mg administered?
Mounjaro is given as a subcutaneous injection (under the skin), typically once a week in the thigh, abdomen, or upper arm. Always follow your healthcare provider's instructions for proper use.
Can I use Mounjaro for weight loss alone?
Mounjaro is not approved solely for weight loss. However, weight reduction can occur as a beneficial effect when used for managing type 2 diabetes.
Are there any side effects of Mounjaro 5mg?
Common side effects include nausea, vomiting, diarrhea, decreased appetite, and constipation. Serious side effects are rare but can include pancreatitis or allergic reactions. Always consult your doctor if side effects persist or worsen.
Can I use Mounjaro if I have type 1 diabetes?
No, Mounjaro is not indicated for type 1 diabetes or diabetic ketoacidosis.
Can I take Mounjaro with other diabetes medications?
Yes, Mounjaro can be used alongside other medications like metformin or insulin. Your doctor will determine the right combination for you.